Skip to main content

EDITORIAL article

Front. Radiol., 05 January 2024
Sec. Neuroradiology
This article is part of the Research Topic Rising Stars in Neuroradiology: 2022 View all 8 articles

Editorial: Rising stars in neuroradiology: 2022

  • 1Department of Neuroradiology, Ruskin Wing, King’s College Hospital NHS Foundation Trust, London, United Kingdom
  • 2School of Biomedical Engineering & Imaging Sciences, King’s College London, Rayne Institute, St. Thomas’ Hospital, London, United Kingdom

Editorial on the Research Topic
Rising stars in neuroradiology: 2022

In this Rising Stars in Neuroradiology: 2022 Research Topic, we highlight the diversity of research performed across the entire breadth of Neuroradiology and have presented advances in theory, experiment, and methodology with applications to compelling problems. In particular we focused on high-quality work of internationally recognized researchers in the early stages of their independent careers.

The Topic includes biomarker development studies incorporating CT, MRI, and PET as well as studies which will have the potential to improve cerebral revascularization and deep brain stimulation neurosurgery. Both preclinical and clinical methodology is also covered in the Topic as are insights into neuroradiology deep learning methodology.

Data from the Third International Stroke Trial (IST-3, a large randomized-controlled trial of intravenous alteplase for ischaemic stroke) is explored by Mair et al. for biomarker development. The authors first identified a cohort of patients who developed medium-large ischaemic lesions within 48 h based on a National Institutes of Health Stroke Scale (NIHSS) threshold. NIHSS > 11 best identified those with medium-large ischaemic lesions. The authors then explored whether the baseline CT of this cohort could be used as a predictive biomarker for thrombolysis outcome. Specifically, CT with normal appearing ischaemic brain tissue was compared to CT with visible lesions. They found that patients with invisible ischaemic lesions—and therefore a clinical-radiological mismatch—allocated to alteplase achieved more favourable outcome than those allocated to control. Prospective testing is now required but these exploratory analyses can plausibly inform the design of future studies where, for example, the time of stroke onset is unknown or outside conventional treatment time limits.

The development of quantitative magnetic resonance imaging (qMRI) methodology was considered by Fischi-Gomez et al. who evaluated three different techniques for estimating the T2 spectra from multi-echo T2 relaxometry in both gray and white matter. The results from their multicentre study suggest that the principal source of variance was the inter-subject variability as opposed to inter-site, inter-session, and inter-run variability. The implication is that multi-site neuroimaging studies can now develop complex tissue microstructure biomarkers by probing compartment-specific T2 relaxation times.

We shift gear towards the development of pre-clinical diagnostic biomarkers of the microbiome-gut-brain axis as proposed by Yi et al. In their pilot study, neurite orientation dispersion and density (NODDI) imaging, and SV2A 18F-SynVesT-1 synaptic density PET imaging is compared in mice with a functional gut microbiome and mice who are germ-free. Higher neurite density and orientation dispersion and decreased synaptic density was seen in the intact mice when compared to age- and sex-matched germ-free mice. Future multiparametric biomarker analyses will likely include metagenomic data as variables, prior to translational studies.

A clinically-orientated case-based overview focusing on the classic imaging characteristics of cerebral venous thrombosis and cerebral venous infarcts is included in this Topic (Li et al.). Of particular interest to readers is the description of the added value of magnetic resonance perfusion imaging and arterial spin-labelling. Future larger studies must now be performed to validate the diagnostic biomarkers described here. Such studies are important because when compared to arterial ischemic strokes, cerebral venous thrombosis has the potential for a more reversible course and favourable prognosis.

In another clinically-motivated article, dual-source CT systems were examined in single- and dual-energy modes by Zhao et al. The incentive for the study is that preoperative stereotactic planning of deep brain stimulation using CT may be degraded by frame-induced metal artefact which limits the visualization of adjacent brain structures. Using a cohort of patients with idiopathic Parkinson's disease, dual-energy modes (120 keV) provided better objective and subjective image quality at lower radiation doses compared to single-energy mode. Further studies comparing different CT systems would help in understanding the generalizability of the results.

The changing landscape of cerebral revascularization surgery in the context of interventional neuroradiology developments was explored by Gallagher et al. The authors described 50 cerebral revascularization procedures carried out over more than a decade. They explored whether, in the context of giant and fusiform cerebral aneurysms, flow-diverting stents have impacted on the use of cerebral revascularization surgery—and subsequently demonstrated trajectories for increasing and decreasing use of the two techniques, respectively. In this new era, where there is a reduction in cerebral revascularization surgical cases, the authors propose that in most European countries formal centralization of cerebral revascularization surgery will lead to the maintenance of high standards and good outcomes.

Optimising methods to label datasets for deep learning was investigated by Benger et al. The study was motivated by a lack of large clinically representative labelled datasets available to train neuroradiology deep learning models. The context of the study was a triage tool to determine whether brain MRIs were normal or abnormal—so that they can be flagged for rapid clinical reporting. The first experiment investigated a non-radiologist labelling strategy which was not pursued as there was a significant reduction in model performance accuracy compared to expert neuroradiologists. The second experiment investigated a junior radiologist labelling strategy which again was not pursued as there was a significant reduction in model performance accuracy. The third experiment explored report labelling as an expedient surrogate for image labelling. The authors showed that a report labelling strategy had a high sensitivity (98.7%), specificity (96.6%) and accuracy (98.5%) regarding separating normal and abnormal studies by leveraging Natural Language Processing (NLP) algorithms. The accuracy of more specific report labelling for multiple disease categories was shown to be variable and dependent on the category. The fourth experiment showed that a combination of axial T2-weighted sequences and those based on diffusion weighted imaging (DWI) were sufficient for training a computer vision triage tool, thereby limiting the number of MRI sequences needed as input. In summary, numerous lessons have been shared with the research community to help with deep learning methodology in neuroradiology.

We expect that the reader will find a useful range of clinically-orientated and methods-based studies in this state-of-the-art Research Topic.

Author contributions

TB: Conceptualization, Formal analysis, Investigation, Project administration, Writing—original draft, Writing—review & editing.

Funding

The author(s) declare financial support was received for the research, authorship, and/or publication of this article.

TB supported by Medical Research Council [MR/W021684/1] and Wellcome Trust [WT 203148/Z/16/Z].

Conflict of interest

The author declares that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Publisher's note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: deep learning, flow diverter, stroke, T2 relaxometry, NODDI, 18F-synvest-1, dual-source CT, cerebral vein thrombosis

Citation: Booth TC (2024) Editorial: Rising stars in neuroradiology: 2022. Front. Radiol. 3:1349600. doi: 10.3389/fradi.2023.1349600

Received: 4 December 2023; Accepted: 8 December 2023;
Published: 5 January 2024.

Edited and Reviewed by: Sotirios Bisdas, University College London, United Kingdom

© 2024 Booth. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Thomas C. Booth thomas.booth@kcl.ac.uk

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.